- Home
- PCRX vs AGS Comparison
PCRX vs AGS Comparison
Compare PCRX & AGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PCRX
- AGS
- Stock Information
- Founded
- PCRX 2006
- AGS 2005
- Country
- PCRX United States
- AGS United States
- Employees
- PCRX N/A
- AGS N/A
- Industry
- PCRX Biotechnology: Pharmaceutical Preparations
- AGS Miscellaneous manufacturing industries
- Sector
- PCRX Health Care
- AGS Consumer Discretionary
- Exchange
- PCRX Nasdaq
- AGS Nasdaq
- Market Cap
- PCRX 1.2B
- AGS 485.4M
- IPO Year
- PCRX 2011
- AGS 2018
- Fundamental
- Price
- PCRX $26.59
- AGS $12.06
- Analyst Decision
- PCRX Buy
- AGS Hold
- Analyst Count
- PCRX 10
- AGS 4
- Target Price
- PCRX $29.30
- AGS $12.63
- AVG Volume (30 Days)
- PCRX 892.8K
- AGS 278.5K
- Earning Date
- PCRX 02-27-2025
- AGS 03-04-2025
- Dividend Yield
- PCRX N/A
- AGS N/A
- EPS Growth
- PCRX N/A
- AGS 150.52
- EPS
- PCRX N/A
- AGS 0.17
- Revenue
- PCRX $694,957,000.00
- AGS $386,033,000.00
- Revenue This Year
- PCRX $5.14
- AGS $10.87
- Revenue Next Year
- PCRX $2.44
- AGS $4.33
- P/E Ratio
- PCRX N/A
- AGS $70.92
- Revenue Growth
- PCRX 4.40
- AGS 12.18
- 52 Week Low
- PCRX $11.16
- AGS $8.23
- 52 Week High
- PCRX $31.67
- AGS $12.09
- Technical
- Relative Strength Index (RSI)
- PCRX 77.75
- AGS 69.77
- Support Level
- PCRX $25.06
- AGS $11.51
- Resistance Level
- PCRX $27.10
- AGS $12.06
- Average True Range (ATR)
- PCRX 1.45
- AGS 0.06
- MACD
- PCRX 0.28
- AGS 0.01
- Stochastic Oscillator
- PCRX 86.23
- AGS 66.79
About PCRX Pacira BioSciences Inc.
Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company has three commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve.
About AGS PlayAGS Inc.
PlayAGS Inc is a designer and supplier of gaming products and services for the gaming industry. The company mainly supplies electronic gaming machines (EGM), server-based systems and back-office systems which are used by casinos, and various gaming locations. Its operating segments are EGM, Table Products, and Interactive. The EGM segment offers a selection of video slot titles developed for the world-wide marketplace as well as EGM cabinets. Its Table Products segments include live proprietary table games and side bets, as well as ancillary table products. The Interactive segment consists of delivering games through mobile apps such as Lucky Play Casino and Vegas Fever. It earns a majority of its revenue from Electronic Gaming Machines segment and geographically from the United States.